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Abstract
Purpose We aimed to ascertain the feasibility of crowdsourcing
via Facebook for medical research purposes; by investigating
surgical, oncological and functional outcome and quality-of-life
(QOL) in patients with pigmented villonodular synovitis (PVNS)
enrolled in a Facebook community (1112 members).
Methods Patients completed online open surveys on demo-
graphics, surgery and clinical outcomes (group 1); and
patient-reported outcome measures (PROMs) including
knee-injury osteoarthritis outcome score (KOOS), hip-
disability osteoarthritis outcome score (HOOS), Toronto ex-
tremity salvage score (TESS) and SF-36 (group 2). Mean
follow-up was 70 months (12–374). Consistency checks were
performed with Cohen’s kappa statistic for intra-rater
agreement.
Results The first survey was completed by 272 patients
(group 1) and 72 patients completed the second (group
2). In group 1, recurrence-rate was 58 % (69/118) after
arthroscopic, 36 % (35/97) after open and 50 % (5/10)
after combined synovectomy (p = 0.003). In group 2,
recurrence-rate was 67 % (26/39) after arthroscopic and
51 % (17/33) after open synovectomy (p = 0.19).
Recurrence-risk was increased for diffuse disease
(OR = 16; 95%CI = 3.2–85; p < 0.001). Mean function
and QOL did not differ after arthroscopic or open
synovectomy: KOOS 49 vs. 58 (p= 0.24), HOOS 62 vs.
53 (p= 0.56), TESS 78 vs. 82 (p= 0.86), SF-36 61 vs. 66
(p= 0.41). Cohen’s kappa statistic for intra-rater agree-
ment was good to outstanding (κ= 0.68–0.95; p< 0.001).
Conclusion Local recurrence-risk was higher for diffuse-
type disease and arthroscopic synovectomy. Functional
outcome and QOL were comparable for both types of
surgery. Gathering data via crowdsourcing seems a prom-
ising and innovative way of evaluating rare diseases in-
cluding PVNS.
Keywords Crowdsourcing . Diffuse-type giant cell tumor .
Facebook . Functional outcome . Pigmented villonodular
synovitis . PVNS . Quality of life
Introduction
Pigmented villonodular synovitis (PVNS) is a rare benign
but locally aggressive giant cell tumour deriving from
synovium, either localized giant cell tumour of tendon
sheath (GCT-TS) or diffuse-type giant cell tumour (Dt-
GCT) [1, 2]. It is most commonly found in the knee
(75 %; Fig. 1) and hip (15 %) [1, 3]. Treatment may
consist of arthroscopic or open synovectomy, intra-
articular radioactive colloids, radiation therapy or system-
ic targeted therapy [4, 5].
Rare diseases, including PVNS, are difficult to investi-
gate as published case series are generally small, of retro-
spective nature and often describe research periods of
several decades with a short follow-up duration.
Therefore, these studies only provide levels of evidence
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III-IV, and clear evidence is lacking as meta-analysis of
gathered data is often not warranted.
With a growing number of patients using social media
as a source of medical information, online patient plat-
forms can also be used as a powerful educational tool.
Gathering patient data via crowdsourcing on social media
can be especially promising and useful in the evaluation
of rare diseases, as large study populations may become
easily available to researchers. Crowdsourcing is the
practice of obtaining services, ideas or content by
collecting contributions from a large group of people
from an online community rather than from traditional
data suppliers. This is already increasingly being used
for meeting the needs of consumers, and we wanted to
investigate if it could be used to evaluate patient
satisfaction, functional outcome and quality of life for
patients with PVNS. Crowdsourcing to obtain big data
can be useful in all fields of medicine, especially regard-
ing the evaluation of rare diseases and patient reported
outcome measures (PROMs). Open online surveys may
also be more attractive and quick to complete for the
modern patient than conventional questionnaires on pa-
per via regular mail.
Several small communities of patients with PVNS exist
on Facebook; however, there is only one community with
over 1100 patients at the time of study (>2000 at the time
of writing). On this forum, patients share information on
their disease, experiences with treating physicians, sur-
gery or other treatments and clinical outcome, and seek
support from fellow patients. From this forum, we learned
that adequate patient information on PVNS is deficient
and that there is a desire among patients to interact with
other patients and professionals and a growing demand
for taking part in scientific research projects on PVNS.
This is also reflected by recent initiatives such as
PatientsLikeMe (www.patientslikeme.com), in which
patients can track their outcomes by sharing their data
and by participating in the design and implementation of
patient-centred trials [6, 7]. Such online patient commu-
nities may allow researchers rapid access to large study
populations that are otherwise hard to assemble in rare
diseases.
The aim of this study was to investigate whether we
could use crowdsourcing via Facebook and online surveys
for medical research purposes on PVNS. More specifical-
ly, we set out to correlate functional outcome and quality
of life (QOL) to patient characteristics, surgical proce-
dures and oncological outcome in patients with PVNS
who were enrolled in a patient community on Facebook.
Materials and methods
In this open survey observational study, patients were re-
cruited to complete questionnaires on their disease
through a patient-initiated campaign on a PVNS patient
community on Facebook (1112 members at time of con-
s u l t i n g ; h t t p s : / / www. f a c e b o o k . c om / g r o u p s /
91851410592/?ref=ts&fref=ts). A first online survey on
demographics, clinical presentation, findings on imaging
and biopsy material, type and localization of disease,
surgical and adjuvant treatment, local recurrences, post-
operative complications, functional outcome, quality of
life (QOL) and follow-up was open from December
2012 to April 2014 (group 1). A second online survey
using standardized and validated questionnaires on
Fig. 1 MR images of a 27 year old male patient with recurrent diffuse
PVNS in the knee after previous anterior arthroscopic synovectomy and
90Yttrium instillation show multiple intra-articular lesions dorsal to the
posterior cruciate ligament, with low signal intensity on T1-weighted
sequences (A) and heterogeneous intermediate signal intensity on T2-
weighted sequences (B) with artefacts due to haemosiderin depositions
being characteristic for PVNS.
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patient-reported outcome measures (PROMs) [8], to eval-
uate functional outcome and QOL, was open from August
2013 to February 2014 (group 2). The latter included
range of motion (ROM), knee injury and osteoarthritis
outcome score (KOOS) [9, 10], hip disability and osteo-
arthritis outcome score (HOOS) [11], Toronto extremity
salvage score (TESS) [12] and short form-36 health sur-
vey (SF-36) [13]. Mean follow-up after index surgery was
70 months (range 12–374). The surveys were developed
via SurveyMonkey® (https://www.surveymonkey.com)
and usability and technical functionality were tested by
the researchers. The surveys were announced on the
Facebook community wall with a first notice of the
study, and repeated requests for compilation after one,
two, five, six and ten months. It was a voluntary survey
and no incentives were offered. All responses were
anonymous and automatically captured into an SPSS 20.
0 file, which was password protected and only accessible
to the researchers. Completeness checks were performed
through JAVAScript and only fully completed surveys
were included in the analysis. Respondents were able to
review and change their answers before submitting.
Unique site visitors were determined by IP addresses,
and in case of duplicate entries only the most recent
ones were included in the analysis. Propensity scores to
adjust for a non-representative sample were not used in
this study, but results were compared with previous results
from the literature. The checklist for Reporting Results of
Internet E-Surveys (CHERRIES) was used (Appendix 1)
[14, 15]. None of the patients were recalled for this study.
In the present study, data were not verified by contacting
treating physicians or patients. By completing the surveys,
patients gave their informed consent for this study. All
procedures performed were in accordance with the ethical
standards of Dutch law (Medical Research involving
Human Subjects Act) and with the 1964 Helsinki decla-
ration and its later amendments. For this type of study
formal consent is not required.
Statistical analysis
Differences in dichotomous data were calculated with
Chi-squared and Fisher’s exact tests and in numerical data
with Mann–Whitney U tests. Multivariable logistic re-
gression analyses were performed to identify factors of
influence on recurrence, including diffuse or localized dis-
ease, localization and type of surgery. To determine
whether the results of this study are reliable, we per-
formed consistency tests by evaluating intra-rater agree-
ment for patients’ answers between both online surveys.
We used Cohen’s kappa statistic to perform consistency
checks by determining intra-rater agreement for patients
that could be cross-linked by IP address in the two online
surveys. Outstanding agreement was defined as κ> 0.80;
substantial agreement as κ= 0.60–0.79; moderate agree-
ment as κ = 0.40–0.59; and poor agreement as κ < 0.40
[16]. Data from the two surveys were not combined but
analysed separately; hence, the occurrence of repeated
measures was not accounted for. We used SPSS 20.0
(SPSS Inc, Armonk, NJ, USA) for statistical analyses.
The level of statistical significance was set at p< 0.05.
Results
All 1112 members of the PVNS patient community on
Facebook, at the time of consulting, could view the on-
line open survey. Participation rate was 26.3 % (293/
1112) in the first survey; and 11.8 % (131/1112) for
SF-36, 5.3 % (59/1112) for KOOS, 0.8 % (9/1112) for
HOOS and 3.1 % (34/1112) for TESS in the second
survey. Completion rate was 92.8 % (272/293) in the
first survey; and 84.7 % (111/131) for SF-36, 86.4 %
(51/59) for KOOS, 100 % (9/9) for KOOS and 100 %
(34/34) for TESS in the second survey.
From group 1, 272 patients were included (Table 1).
They originated from 23 countries and underwent arthro-
scopic or open synovectomy between 1982 and 2012.
Primary surgery was arthroscopic synovectomy
(n= 118), open synovectomy (n= 97), combined arthro-
scopic and open synovectomy (hybrid synovectomy;
n = 10) or unknown (n= 47). One hundred twenty two
patients reported at least one local recurrence, 124 pa-
tients had no recurrences (Table 2). Mean number of
surgeries was 2.6 (1–9). Final surgery was open
synovectomy (n = 52), arthroscopic synovectomy
(n = 36), hybrid synovectomy (n = 10) or unknown
(n = 24). Total hip arthroplasty was required in 13/25
and total knee arthroplasty in 17/199 (p < 0.001).
Adjuvant treatment was radiation therapy (n= 30), radio-
active colloid instillation with 90Yttrium (n = 18), M-
CSFR targeted tyrosine kinase inhibitor imatinib (n= 8)
or nilotinib (n= 2), cryosurgery (n= 3) or methotrexate
(n= 1).
From group 2, 72 patients with PVNS in the knee or
hip joint and a minimum follow-up of one year were
included (Table 1). The knee was affected in 64 patients
(52 diffuse; 12 localized) and the hip in eight (six dif-
fuse; two localized). Other localizations (n= 18; e.g. an-
kle, elbow and shoulder) were excluded from PROMs
analyses, as we wanted to focus on the two most com-
mon localizations; however, they were used for consis-
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tency checks between both surveys. Primary surgery was
arthroscopic synovectomy (n= 38) or open synovectomy
(n = 34). Recurrence rates are listed in Table 2. Mean
number of surgeries was 2.5 (1–9). Recurrences were
treated with open synovectomy (n = 16), arthroscopic
synovectomy (n = 15) or complete resection and joint
arthroplasty (n= 12). Total hip arthroplasty was required
in 6/8 and total knee arthroplasty in 7/64 (p = 0.004).
Adjuvant treatment was radiation therapy (n = 12),
90Yttrium (n = 9), imatinib (n = 1) or nilotinib (n = 1).
Diffuse disease increased recurrence risk (odds ratio
[OR] = 16; 95 % confidence interval [CI] = 3.2–85;
p = 0.001; Table 3). Mean functional and QOL results
did not differ significantly after primary arthroscopic or
open synovectomy (Table 4). Final surgery resulted in a
mean TESS of 88 after arthroscopic synovectomy, 68
after open synovectomy and 69 after total joint
arthroplasty (p= 0.017). Joint replacement surgery result-
ed in lower functional scores compared with joint sal-
vage: TESS 69 vs. 82 (p = 0.010), KOOS 34 vs. 55
(p = 0.031) and SF-36 49 vs. 66 (p = 0.020). Mean
ROM was lower for patients with diffuse disease (117
vs. 151 degrees; p= 0.024) and for recurrent disease re-
quiring repeat surgery (113 vs. 138 degrees; p= 0.046).
Consistency checks were performed with Cohen’s kappa
statistic for intra-rater agreement; 66 patients could be cross-
linked between both surveys through IP address. Cohen’s kap-
Table 2 Local recurrences after
synovectomy for PVNS in the
knee or hip







% n % n % n
Total group 58 % 69/118 36 % 35/97 50 % 5/10 0.003
Group 2 (n= 72)
Total group 67 % 26/39 51 % 17/33 – – 0.19
Localized disease 25 % 2/8 0 % 0/6 – – 0.31
Diffuse disease 77 % 23/30 64 % 18/28 – – 0.23
*Combined arthroscopic and open synovectomy
Table 3 Factors of influence on recurrence rate after synovectomy for
PVNS in the knee or hip
OR 95 % CI p-value
Diffuse disease 16 3.2–85 0.001
Arthroscopic synovectomy 2.2 0.74–6.6 0.16
Localization in knee 1.3 0.27–5.9 0.77
Arthroscopic synovectomy 1.7 0.67–4.5 0.26
OR odds ratio, CI confidence interval
Table 1 Patient, tumour and treatment characteristics
Group 1 (n= 272) Group 2 (n= 72)
mean range mean range
Age (years) 32 11–67 31 15–58
Follow-up (months) U U 68 12–374
Number of surgeries 2.6 1–9 2.5 1–9
n % n %
Gender
Female 230 85 56 78
Male 42 15 16 22
Localization
Knee 199 73 64 89
Hip 25 9 8 11
Ankle 31 11.5 – –
Elbow 8 3 – –
Foot 4 1.5 – –
Shoulder 4 1.5 – –
Hand 1 0.5 – –
Type of disease
Diffuse disease U U 58 81
Localized disease U U 14 19
Pre-operative complaints
Pain 202 74 25 35
-At rest U U 19 26
-During exercise U U 19 26
-At night U U 16 22
Swelling 202 74 25 35
Stiffness/limited ROM 113 41 25 35
Locking 61 22 U U
Surgical treatment
Arthroscopic synovectomy 118 43 38 53
Open synovectomy 97 36 34 47
Combined hybrid synovectomy 10 4 – –
Unknown 47 17 – –
U unknown, ROM range of motion
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pa statistic for the two online surveys was outstanding for
tumour localization with κ = 0.95 (p < 0.001), joint
arthroplasty with κ=0.88 (p<0.001) and adjuvant treatment
with κ=0.82 (p<0.001); and substantial for primary surgical
treatment with κ = 0.78 (p < 0.001) and recurrences with
κ=0.68 (p<0.001).
Discussion
In this study, we investigated whether we could use
crowdsourcing via Facebook and online surveys for med-
ical research purposes on PVNS. We set out to correlate
functional outcome and QOL to patient characteristics,
surgical procedures and oncological outcome in patients
with PVNS who were enrolled in a patient community
on Facebook. We concluded that the recurrence risk was
highest for diffuse disease and after arthroscopic
synovectomy. Lower functional results were reported
for patients with diffuse disease, for patients with recur-
rences requiring repeat surgery, and for patients eventu-
ally requiring joint replacement surgery.
To determine whether the results of this study are
reliable and whether crowdsourcing via social media is
feasible in medical research, we performed consistency
tests by evaluating intra-rater agreement for patients’ an-
swers between both online surveys, which was substan-
tial to outstanding for most study variables. The some-
what lower agreement in follow-up questions can be ex-
plained by the time interval between the two surveys as
patients may have experienced a recurrence after filling
out the first survey. In addition, we compared our results
with previous publications on PVNS to assess the repre-
sentativeness of our sampling frame [17] (Tables 3 and
5). An advantage of this comparison may be the deter-
mination of accurateness of the use of crowdsourcing
and the reliability of the obtained data. Possible disad-
vantages of crowdsourcing may include selection bias
through the sampling method, inhibiting comparison of
results with previously published reports. The average
age of 32 years at onset of disease in this study matches
known epidemiology of PVNS (<40 years) [1, 2, 36].
Localization of PVNS in this study (73 % knee, 9 %
hip, 18 % other) was also comparable to percentages
described in literature (75 % knee, 15 % hip, 10 % oth-
er). Multifocal PVNS is rare and was not reported in this
study [36]. Women were over-represented (78 %) when
compared with known epidemiology of PVNS; possibly
indicating that women are more likely to be on Facebook
and to seek information via support groups [37]. All
study variables were distributed equally between men
and women. Women scored somewhat lower on SF-36
subdomains physical functioning, pain and PCS; all other
functional and QOL scores did not differ between men
and women (results not shown). Proportions of arthro-
scopic and open synovectomy [4] and total knee or hip
arthroplasty were comparable to those previously pub-
lished [38, 39].
Mean follow-up of approximately six years (range 1–
31) was longer when compared with the majority of
previously published reports [3, 19, 23, 29, 31, 32].
Together with the relatively high recurrence rates in this
study (58–77 % after arthroscopic and 36–64 % after
open synovectomy), this may indicate that to date, an
underestimate of the true local recurrence rate of PVNS
has been published.
Functional results after surgical treatment for PVNS have
been reported (Table 5) [3, 18–32], but comparison is difficult,
as functional results were not specified for diffuse and local-
ized disease, type of surgery, primary or recurrent disease and
different localizations. In this study, there was no difference in
functional outcome and QOL between patients who
underwent primary arthroscopic or open synovectomy.
However, the long course of disease and the need for multiple
surgeries has previously been reported to result in worse func-
tional results in a large number of patients [23]; and in this
study, lower functional results were also reported for patients
with diffuse disease, with recurrences requiring repeat surgery,
Table 4 Functional outcome and
QOL after primary synovectomy
for PVNS in the knee or hip
Arthroscopic synovectomy Open synovectomy p-value
mean range mean range
ROM (degrees) 124 80–170 129 65–170 0.65
KOOS 49 8–92 58 34–92 0.24
HOOS 62 51–72 53 31–67 0.56
TESS 78 33–100 82 63–97 0.86
SF-36 61 11–100 66 21–98 0.41
ROM range of motion, TESS Toronto extremity salvage score, KOOS knee injury and osteoarthritis outcome
score, HOOS hip disability and osteoarthritis outcome score, SF-36 short form 36 health survey
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Table 5 Literature overview on oncological and functional results after arthroscopic and open synovectomy for PVNS
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and for patients eventually requiring joint replacement
surgery.
Our study has several limitations. First, the low participa-
tion rate in this study (26.3 %) may be explained by several
arguments, including the voluntary character of the survey,
and the attention paid to the survey by the Facebookmembers;
maybe they didn’t see the requests on their wall, didn’t have
time to compile the questionnaires or didn’t feel the need to
add to a scientific research project. This is also of concern
when similar studies involving social media are performed
in medicine, as it may induce selection bias. In regards to this
potential selection bias, patients who are currently unsatisfied
with their situation may be more likely to enrol in a patient
community on Facebook and to complete online surveys
concerning functional and QOL results. However, the oppo-
site may also be true for satisfied patients who are willing to
share their experience and to improve awareness on this rare
disease. Second, patients were not uniformly diagnosed and
treated for PVNS, as they were collected from 23 different
countries and treated by various surgeons without
distinguishing between peripheral and tertiary referral centres.
However, we believe that it represents a randomly chosen
group of patients, perfectly reflecting the current worldwide
situation and underlining the importance of centralization of
care for musculoskeletal tumours [40]. Third, the accuracy of
surgical data is subjective to the understanding of patients;
data obtained from patients were not verified by contacting
treating physicians. We considered this beyond the scope of
the current study but we deem it valuable in future
crowdsourcing studies via social media. Yet, PROMs are
considered more reliable in reporting subjective patient out-
comes when compared to the evaluation by treating physician,
and are more often required by the FDA [8, 41].
In addition to using social media for crowdsourcing pur-
poses in rare diseases, it may also increase the readership and
impact of scientific publications apart from the indexed im-
pact factor.
An increasing number of scientific papers can be found
through social media such as Facebook, Twitter, LinkedIn
and ResearchGate; and journals should explore these plat-
forms and use it in a constructive way to increase the scientific
exposure [42].
In conclusion, gathering data via crowdsourcing in a pa-
tient community on Facebook seems a promising and innova-
tive way of evaluating rare diseases, as it provides for a rep-
resentative and large sample of patients with long-term fol-
low-up and valid clinical outcome data. The results of this
study suggest that local recurrence risk and functional out-
come were both negatively influenced by diffuse disease,
which comprises a large part of the joint, is difficult to resect
completely and often requires repeat surgery, especially after
arthroscopic synovectomy.
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Table 5 (continued)




































F female, M male, NR not reported, KSS Knee Society score, TLKS Tegner-Lysholm knee score, LKS Lysholm knee scale, IKDC International Knee
Documentation Committee, SD standard deviation
1 Functional outcome was not further specified
2 Functional outcome was based on pain, walking status, joint swelling, effusion, crepitus, locking, instability and ROM
3Functional outcome was based on pain, synovitis, joint swelling and ROM
4Functional outcome was obtained from 10/26 patients
5 Functional outcome was obtained from 14/50 patients
6 Functional results after open synovectomy/arthroscopic synovectomy
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Appendix: Data reporting guidelines
Appendix 1: CHERRIES checklist
Table 6 Checklist for reporting results of internet E-surveys (CHERRIES)
Item category Checklist item This study
Design Describe survey design Target population is 1112 patients enrolled in BPVNS is pants!!^ community
on Facebook
IRB approval and informed consent
process
IRB approval Approval of the ethics committee of our institution was waived because this
study did not fall under the scope of the Dutch law on Medical Research
Involving Human Subjects Act (WMO).
Informed consent Informed consent was included in the questionnaires. Length of survey was
explained on the first page of survey, investigators PhD student and
consultant orthopedic oncologist from a tertiary centre in the Netherlands,
purpose of study to increase knowledge and awareness on this rare disease
including PROMs.
Data protection Results from survey visible to researchers only, password protected.
Development and pre-testing Development and testing Survey developed via surveymonkey.com, usability and technical
functionality was tested by researchers.
Recruitment process and description
of the sample having access to the
questionnaire
Open survey versus closed
survey
Open survey on community on Facebook
Contact mode Contact with participants was made through the Facebook community, links
to the surveys were provided here.
Advertising the survey The e-survey was announced on the Facebook community wall with a first
notice of the study, and repeated requests after 1, 2, 5, 6 and 10 months.
See Appendix I (below).
Survey administration Web/E-mail E-survey posted on a website (i.e. Facebook community on PVNS).
Responses were automatically captured into an SPSS 20.0 file, which was
only accessible to the researchers.
Context Facebook community on PVNS, mostly patients but also family members and
the research from this study. Normally looking to share information and
personal experiences concerning this rare disease, its (surgical) treatment,
recovery duration, tips and tricks; so best summarized as an information
and support group.
Women are somewhat overrepresented when compared with known
epidemiology of PVNS, and may be more likely to seek information via
support groups?
Patients from countries all over the world, including developing and
developed countries, age groups of Facebook users matches known
epidemiology.
Mandatory/voluntary Voluntary survey
Incentives No incentives were offered
Time/date December 2012–April 2014
May 2013–May 2014
Randomization of items or
questionnaires
No randomization, standardizes PROMs
Adaptive questioning No adaptive questioning, standardized PROMs





Number of screens (pages) 1 webpage per survey, if applicable
Completeness check Yes, completeness checks were done through JAVAScript, consistency checks
were not performed, not applicable options were included, general
questions included some open and some multiple option questions,
PROMs were standardized validated questionnaires with enforced one-
response-option.
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Appendix I: Survey announcements 12-05-2013
Announcement of study initiative: Knowledge on QOL and functional
results after treatment of PVNS is lacking; validated questionnaires will
be launched here soon and your valuable data will be used to create
awareness and improve treatment protocols as were recently published
[REF JSO, JBJS Br].
01-08-2013 Announcement including link to survey: Please fill in
this first Facebook-based research initiative on functional outcome and
quality of life of patients with PVNS and allow us to evaluate your quality
of life and limb or joint function in order to improve the current treatment
protocols and therewith the functional outcome and quality of life of
patients with PVNS in the future. All data will be handled with care
and are only used according to the rules of good clinical and research
practice. Data stored will not be traceable to your personal details, all will
be anonymized.
Further announcements including link to survey were provided
after 1, 2, 5, 6 and 10 months. (19-08-2013, 31-08-2013, 03-09-2013, 17-
09-2013, 22-09-2013, 22-12-2013, 31-12-2013, 29-01-2014, 23-05-2014).
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
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Table 6 (continued)
Item category Checklist item This study
Review step Respondents were able to review and change their answers
Response rates Unique site visitor Unique site visitors were determined by IP addresses.




Total 274/1112= 24,6 %
SF36 131/1112= 11.8 %
KOOS 59/1112= 5.3 %
HOOS 9/1112= 0.8 %
TESS 34/1112= 3.1 %
Participation rate (ratio of




Total 270/274 = 98.5 %
SF36 131/131 = 100 %
KOOS 59/59 = 100 %
HOOS 9/9 = 100 %
TESS 34/34 = 100 %
Completion rate (ratio of users
who finished the survey/users
who agreed to participate)
Completion/completeness rate
SF36 111/131 = 84.7 %
KOOS 51/59 = 86.4 %
HOOS 9/9 = 100 %
TESS 34/34 = 100 %
Preventing multiple entries from the
same individual
Cookies used No cookies were used
IP check Duplicate database entries having the same user ID/IP address were
eliminated before analysis; the most recent entries were included.
Log file analysis See above
Registration N. A.
Analysis Handling of incomplete
questionnaires




Statistical correction Propensity scores to adjust for the non-representative sample were not used in
this study
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